International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019.
 Stirban A, et al. Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol Metab. 2013; 3:94–108.
 Ali A, et al. Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes. Pak J Med Sci. 2013; 29(4):899–902.
 WHO. Non-communicable diseases country profile 2014. http://www.who.int/nmh/publications/ncd-profiles-2014/en/.
 Gaede P, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383–93.
 Lewis, B.P., et al. Prediction of mammalian microRNA targets. Cell. 2003; 115(7): 787-98.
 Caporali A, et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation. 2011; 123(3):282–291.
 Caporali A, et al. p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia. Nat Commun. 2015; 6:8024.
 La Sala L, et al. Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells. Cardiovasc Diabetol. 2016; 15:71.
 Saunders MA, et al. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA. 2007; 104(9):3300–3305.
 Nam, J.W., et al. Human microRNA prediction through a probabilistic co-learning model of sequence and structure. Nucleic Acids Research. 2005; 33(11): p3570-3581.
 Davis, B.N., et al. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell. 2010; 39(3): 373-84.
 Haas, U., et al. MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3 '-UTR via altered RNA structure. Rna Biology. 2012; 9(6): 924-937.
 Sethupathy P, et al. MicroRNA target site polymorphisms and human disease. Trends Genet. 2008; 24(10):489–497.
 CARDIoGRAMplusC4D Consortium, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013; 45(1):25–33.
 Clarke P, et al. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med. 2003; 20(6):442–450.
 Qi L, et al. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA. 2013; 310(8):821–828.
 Pickrell JK, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature. 2010; 464(7289):768‐772.
 Heinig M, et al. A trans-acting locus regulates an anti-viral expression network and Type 1 diabetes risk. Nature. 2010; 467(7314):460‐464.
 Lin X, et al. Genome-wide integrative analysis identified SNP-miRNA-mRNA interaction networks in peripheral blood mononuclear cells. Epigenomics. 2017; 9(10):1287–1298.
 Kamiński MJ, et al. In-silico identification of cardiovascular disease-related SNPs affecting predicted microRNA target sites. Pol Arch Med Wewn. 2013; 123(7-8):355-363.
 Hu Y, et al. Suppression of miRNA let-7i-5p promotes cardiomyocyte proliferation and repairs heart function post injury by targetting CCND2 and E2F2. Clin Sci (Lond). 2019; 133(3):425‐441.
 Choi J, et al. Gelidium elegans Extract Ameliorates Type 2 Diabetes via Regulation of MAPK and PI3K/Akt Signaling. Nutrients. 2018; 10(1):51.
 Feng C, et al. SHBG expression is correlated with PI3K/AKT pathway activity in a cellular model of human insulin resistance. Gynecol Endocrinol. 2018; 34(7):567‐573.
 King GL, et al. Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture. Diabetes. 2016; 65(6):1462‐1471.
 Wu JHY, et al. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017; 5(12):965‐974.
 Marklund M, et al. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019; 139(21):2422‐2436.
 Yan W, et al. Characteristics of B cell‑associated gene expression in patients with coronary artery disease. Mol Med Rep. 2016;13(5):4113‐4121.
 Fuster JJ, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842‐847.
 Ki SM, et al. CEP41-mediated ciliary tubulin glutamylation drives angiogenesis through AURKA-dependent deciliation. EMBO Rep. 2020; 21(2):e48290.
 Randhawa PK, et al. The Ras activator RasGRP3 mediates diabetes-induced embryonic defects and affects endothelial cell migration. Circ Res. 2011; 108(10):1199‐1208.
 Gao ZF, et al. microRNA-107 protects against inflammation and endoplasmic reticulum stress of vascular endothelial cells via KRT1-dependent Notch signaling pathway in a mouse model of coronary atherosclerosis. J Cell Physiol. 2019; 234(7):12029‐12041.
 Fang HC, et al. KRT1 gene silencing ameliorates myocardial ischemia-reperfusion injury via the activation of the Notch signaling pathway in mouse models. J Cell Physiol. 2019; 234(4):3634‐3646.
 Omer Faruk Karacorlu, et al. Circulating miR-196a-5p miR-373-3p and miR-375: Novel candidate biomarkers for diagnosis of acute coronary syndrome. Meta Gene. 2018; 17.
 Li Y, et al. miR-202-5p protects rat against myocardial ischemia reperfusion injury by downregulating the expression of Trpv2 to attenuate the Ca 2+ overload in cardiomyocytes. J Cell Biochem. 2019; 120(8):13680‐13693.